Corneal epithelial healing rates after topical nucleotides

Area of Science:

• Ophthalmology
• Cell Biology
• Pharmacology

Background:

• Corneal epithelial defects are common ocular injuries.
• Understanding factors that promote or inhibit epithelial regrowth is crucial for effective treatment.
• Cyclic nucleotides like cAMP and cGMP play roles in cellular processes, including cell proliferation and differentiation.

Purpose of the Study:

• To investigate the effect of exogenous cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) on corneal epithelial wound healing in a rabbit model.
• To determine if theophylline or epinephrine could enhance the effects of cAMP on corneal epithelial regrowth.
• To assess the impact of pilocarpine on cGMP's effect on corneal wound healing.

Main Methods:

• Discrete epithelial lesions (28mm²) were created in rabbit corneas.
• Lesions were topically treated multiple times daily with vehicle, varying concentrations of Db cAMP, or cyclic GMP.
• Combinations with theophylline, epinephrine, or pilocarpine were also tested.
• Lesion size was monitored photographically over 48 hours.

Main Results:

• None of the tested treatment regimens, including Db cAMP or cyclic GMP alone or in combination with other agents, significantly influenced the rate of corneal epithelial regrowth.
• The concentrations of cyclic nucleotides used did not demonstrate a therapeutic effect on healing speed.
• No observable acceleration or deceleration of lesion closure was detected across all experimental groups.

Conclusions:

• Exogenous administration of cyclic AMP or cyclic GMP, at the tested concentrations and in combination with theophylline, epinephrine, or pilocarpine, does not promote corneal epithelial wound healing in rabbits.
• Further research may be needed to explore different concentrations, delivery methods, or other signaling pathways involved in corneal repair.
• The findings suggest that modulating intracellular cyclic nucleotide levels through these specific agents is not a viable strategy for enhancing corneal epithelial regeneration.